ES2347485T3 - Uso de la proteina s100a12, como marcador para el cancer colorrectal. - Google Patents

Uso de la proteina s100a12, como marcador para el cancer colorrectal. Download PDF

Info

Publication number
ES2347485T3
ES2347485T3 ES07725293T ES07725293T ES2347485T3 ES 2347485 T3 ES2347485 T3 ES 2347485T3 ES 07725293 T ES07725293 T ES 07725293T ES 07725293 T ES07725293 T ES 07725293T ES 2347485 T3 ES2347485 T3 ES 2347485T3
Authority
ES
Spain
Prior art keywords
marker
sample
crc
stool
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07725293T
Other languages
English (en)
Spanish (es)
Inventor
Norbert Wild
Herbert Andres
Ursula Garczarek
Andrea Geistanger
Marie-Luise Hagmann
Johann Karl
Friedemann Krause
Michael Pfeffer
Wolfgang Rollinger
Michael Tacke
Michael Thierolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2347485T3 publication Critical patent/ES2347485T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES07725293T 2006-05-19 2007-05-16 Uso de la proteina s100a12, como marcador para el cancer colorrectal. Active ES2347485T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06010439 2006-05-19
EP06010439 2006-05-19

Publications (1)

Publication Number Publication Date
ES2347485T3 true ES2347485T3 (es) 2010-10-29

Family

ID=37087565

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07725293T Active ES2347485T3 (es) 2006-05-19 2007-05-16 Uso de la proteina s100a12, como marcador para el cancer colorrectal.

Country Status (15)

Country Link
US (3) US20090286328A1 (https=)
EP (1) EP2021794B8 (https=)
JP (1) JP4942813B2 (https=)
KR (1) KR101147586B1 (https=)
CN (1) CN101449163B (https=)
AT (1) ATE471512T1 (https=)
AU (1) AU2007251933B2 (https=)
BR (1) BRPI0711763A2 (https=)
CA (1) CA2651709A1 (https=)
DE (1) DE602007007209D1 (https=)
DK (1) DK2021794T3 (https=)
ES (1) ES2347485T3 (https=)
MX (1) MX2008014482A (https=)
PL (1) PL2021794T3 (https=)
WO (1) WO2007134779A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10957217B2 (en) 2006-08-25 2021-03-23 Ronald A. Weitzman Population-sample regression in the estimation of population proportions
US11151895B2 (en) * 2006-08-25 2021-10-19 Ronald Weitzman Population-sample regression in the estimation of population proportions
ATE521894T1 (de) * 2007-11-20 2011-09-15 Hoffmann La Roche Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
JP5461201B2 (ja) * 2008-01-31 2014-04-02 学校法人慶應義塾 抗がん剤感受性の判定方法
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
CN103033623A (zh) * 2012-12-10 2013-04-10 天津市协和医药科技集团有限公司 人m2型丙酮酸激酶化学发光免疫分析试剂盒及制备方法
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
CN104178562B (zh) * 2013-05-21 2018-11-09 生物梅里埃股份公司 一种大肠癌预后试剂盒
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
CN107271681A (zh) * 2017-06-05 2017-10-20 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用
AU2019252672B2 (en) 2018-04-12 2025-08-14 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
WO2021015619A1 (en) * 2019-07-23 2021-01-28 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Progression markers for colorectal adenomas
AU2020365127B2 (en) * 2019-10-18 2026-04-09 Exact Sciences Corporation Multiple analyte fecal antigen testing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137064A (ja) * 1984-12-07 1986-06-24 Fujirebio Inc 大腸癌の予備スクリ−ニング方法
DE3838900A1 (de) * 1988-11-17 1990-05-23 Scheefers Borchel Ursula Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung
JPH02193071A (ja) * 1989-01-20 1990-07-30 Green Cross Corp:The ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法
JPH08238090A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Ｔｉｍｐ１を用いた検出方法
EP2295976A1 (en) * 2003-03-08 2011-03-16 Auvation Ltd Markers for colorectal cancer
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
ATE494391T1 (de) * 2004-07-23 2011-01-15 Aspenbio Pharma Inc Verfahren und vorrichtungen zur diagnose von appendizitis

Also Published As

Publication number Publication date
JP2009537798A (ja) 2009-10-29
AU2007251933A1 (en) 2007-11-29
MX2008014482A (es) 2008-11-27
WO2007134779A1 (en) 2007-11-29
CN101449163B (zh) 2014-06-25
DK2021794T3 (da) 2010-10-11
HK1133295A1 (en) 2010-03-19
BRPI0711763A2 (pt) 2011-12-06
EP2021794B1 (en) 2010-06-16
US20150192587A1 (en) 2015-07-09
EP2021794B8 (en) 2010-08-18
US20170115294A1 (en) 2017-04-27
DE602007007209D1 (de) 2010-07-29
CN101449163A (zh) 2009-06-03
US20090286328A1 (en) 2009-11-19
KR20090007454A (ko) 2009-01-16
EP2021794A1 (en) 2009-02-11
AU2007251933B2 (en) 2011-05-12
JP4942813B2 (ja) 2012-05-30
PL2021794T3 (pl) 2010-12-31
KR101147586B1 (ko) 2012-08-23
CA2651709A1 (en) 2007-11-29
ATE471512T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
ES2347485T3 (es) Uso de la proteina s100a12, como marcador para el cancer colorrectal.
ES2780192T3 (es) Folato receptor alfa como marcador diagnóstico y de pronóstico para cánceres que expresan folato receptor alfa
ES2291750T3 (es) Uso de nicotinamida-n-metiltransferasa como marcador de cancer colorrectal.
ES2439966T3 (es) PACAP como marcador para el cáncer
ES2384125T3 (es) Apex como marcador de cáncer de pulmón
ES2434017T3 (es) Utilización del s-ErbB-3 como marcador de cáncer
ES2345167T3 (es) Utilizacion de nnmt como marcador de cancer de pulmon.
US20100159479A1 (en) Timp-1 as a marker for colorectal cancer
ES2316997T3 (es) Uso de la proteina proteinasa 3 (prn3) y del inhibidor de la elastasa leucocitaria (ileu) como un marcador para el cancer colorrectal.
ES2408964T3 (es) ASC como marcador del cáncer de pulmón
ES2271892T3 (es) Uso de la proteina masp como marcador para el cancer colorrectal.
ES2323429T3 (es) Uso de la asc, como marcador para cancer colorrectal.
ES2285469T3 (es) Utilizacion de la proteina celular transportadora de acido retinoico de tipo ii (crabp ii) como marcador del cancer de mama.
ES2315673T3 (es) Uso de la subunidad de 3 de proteina activadora de proteasoma (pse3) como marcador de cancer colorrectal.
ES2305866T3 (es) Uso de la proteina spee (espemidina sintasa) como marcador en el cancer de mama.
ES2318318T3 (es) Uso de la proteina spee /espermidina sintasa) como marcador en el cancer colorectal.
HK1142130A (en) Use of timp-1 as a marker for colorectal cancer
US20070218510A1 (en) Use of protein PSA3 as a marker for colorectal cancer
HK1133295B (en) Use of protein s100a12 as a marker for colorectal cancer